American Health Packaging recalls GlipiZIDE Extended-Release Tablets, 2.5 mg, 30 Tablets (3 blister cards each with 10 individually blistered doses), Rx…
- Recall date
- September 17, 2021
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0020-2022
- FDA classification
- Class II
- Brand / firm
- American Health Packaging
- Sold / distributed
- Nationwide within the USA
Why it was recalled
Failed Dissolution Specifications: results were above specification.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
GlipiZIDE Extended-Release Tablets, 2.5 mg, 30 Tablets (3 blister cards each with 10 individually blistered doses), Rx only, Manufactured by: Patheon Pharmaceuticals Inc., Cincinnati, OH 45237; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054. Carton NDC#: 68084-295-21 (Individual Dose NDC: 68084-295-11)
Get recall alerts
Free email alert whenever American Health Packaging has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: American Health Packaging